SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Appaloosa Management LP et al – ‘SC 13D’ on 8/7/97 re: Imagyn Medical Inc

As of:  Thursday, 8/7/97   ·   Accession #:  923088-97-13   ·   File #:  5-47905

Previous ‘SC 13D’:  ‘SC 13D/A’ on 7/14/97   ·   Next:  ‘SC 13D/A’ on 8/18/97   ·   Latest:  ‘SC 13D/A’ on 12/23/97

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer

 8/07/97  Appaloosa Management LP et al     SC 13D                 1:13K  Imagyn Medical Inc

General Statement of Beneficial Ownership   —   Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D      General Statement of Beneficial Ownership             13±    48K 


Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
4Item 1. Security and Issuer
"Item 2. Identity and Background
"Item 3. Source and Amount of Funds or Other Consideration
"Item 4. Purpose of Transaction
"Item 5. Interest in Securities of the Issuer
"Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
"Item 7. Material to Be Filed as Exhibits
7Shares
SC 13D1st “Page” of 8TOCTopPreviousNextBottomJust 1st
 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ___)* Imagyn Medical, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 45245K105 (CUSIP Number) Jonathan Green, Esq. Appaloosa Management L.P. 51 John F. Kennedy Parkway Short Hills, New Jersey 07078 (201) 376-5400 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) August 6, 1997 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1 (b)(3) or (4), check the following box . Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosure provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Exhibit Index: Page 7 Page 1 of 10 Pages
SC 13D2nd “Page” of 8TOC1stPreviousNextBottomJust 2nd
SCHEDULE 13D CUSIP No. 45245K105 Page 2 of 10 Pages 1 Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person Appaloosa Management L.P. 2 Check the Appropriate Box If a Member of a Group* a. b. X 3 SEC Use Only 4 Source of Funds* N/A 5 Check Box If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) 6 Citizenship or Place of Organization Delaware 7 Sole Voting Power Number of433,600 Shares Beneficially 8 Shared Voting Power Owned By-0- Each Reporting 9 Sole Dispositive Power Person433,600 With 10 Shared Dispositive Power -0- 11 Aggregate Amount Beneficially Owned by Each Reporting Person 433,600 12 Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares* 13 Percent of Class Represented By Amount in Row (11) 5.42% 14 Type of Reporting Person* PN *SEE INSTRUCTIONS BEFORE FILLING OUT!
SC 13D3rd “Page” of 8TOC1stPreviousNextBottomJust 3rd
SCHEDULE 13D CUSIP No.45245K105 Page 3 of 10 Pages 1 Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person David A. Tepper 2 Check the Appropriate Box If a Member of a Group* a. b. X 3 SEC Use Only 4 Source of Funds* N/A 5 Check Box If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) 6 Citizenship or Place of Organization United States 7 Sole Voting Power Number of433,600 Shares Beneficially 8 Shared Voting Power Owned By-0- Each Reporting 9 Sole Dispositive Power Person433,600 With 10 Shared Dispositive Power -0- 11 Aggregate Amount Beneficially Owned by Each Reporting Person 433,600 12 Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares* 13 Percent of Class Represented By Amount in Row (11) 5.42% 14 Type of Reporting Person* IN *SEE INSTRUCTIONS BEFORE FILLING OUT!
SC 13D4th “Page” of 8TOC1stPreviousNextBottomJust 4th
SCHEDULE 13D Item 1.Security and Issuer This statement on Schedule 13D relates to shares of the common stock, par value $0.001 per share (the "Shares"), of Imagyn Medical, Inc., a Delaware corporation (the "Company"). The principal executive offices of the Company are located at 27651 La Paz Road, Laguna Miguel, California 92677. Item 2.Identity and Background This statement on Schedule 13D is being filed by Appaloosa Management L.P., a Delaware limited partnership (the "Manager"), and David A. Tepper ("Mr. Tepper", and together with the Manager, the "Reporting Persons"). A copy of the Joint Filing Agreement between the Reporting Persons is annexed hereto as Exhibit A. The general partner of the Manager is Appaloosa Partners Inc., a Delaware corporation, of which Mr. Tepper is the sole stockholder and President. The Manager is the general partner of Appaloosa Investment Limited Partnership I, a Delaware limited partnership (the "Partnership"). The Manager acts as an investment adviser to the Partnership, Palomino Fund Ltd. ("Palomino") and Reliance Standard Life Insurance Company ("Reliance"). Reliance is beneficially owned by Delphi Financial Group, Inc., a publicly-held, insurance holding company ("Delphi"). The address of the principal business and principal office of the Manager is 51 John F. Kennedy Parkway, Short Hills, New Jersey 07078. The business address of Mr. Tepper is 51 John F. Kennedy Parkway, Short Hills, New Jersey 07078. The present principal occupation or employment of Mr. Tepper is President of Appaloosa Partners Inc. The address of the principal business and principal office of Palomino is c/o Trident Trust Company (Cayman) Ltd., 1 Capital Place, P.O. Box 847, Grand Cayman, Cayman Islands. The address of the principal business and principal office of Reliance is 2501 Parkway, Philadelphia, Pennsylvania 19130. The address of the principal business and principal office of Delphi is 1105 North Market Street, Wilmington, Delaware 19899. The Partnership, Palomino and Reliance are sometimes referred to herein collectively as the "Accounts"1- . During the last five years, none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction resulting in a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. Mr. Tepper is a citizen of the United States. Item 3. Source and Amount of Funds or Other Consideration Of the 433,600 Shares held by the Reporting Persons, 337,258 Shares were purchased with the personal funds of the Partnership, 18,318 Shares were purchased with the working capital of Palomino and 78,024 Shares were purchased with the working capital of Reliance. Item 4.Purpose of Transaction The purpose of the acquisition by the Reporting Persons of the Shares is for investment. The Reporting Persons may consider making additional purchases of the Shares in open- market or private transactions, the extent of which purchases would depend upon prevailing market and other conditions. Alternatively, the Reporting Persons may sell all or a portion of their Shares in open-market or private transactions, depending upon prevailing market conditions and other factors. Except as indicated above, the Reporting Persons have no plans or proposals which relate to or would result in any of the events, actions or conditions specified in paragraphs (a) through (j) of Item 4 of this Form. Item 5.Interest in Securities of the Issuer (a) This statement on Schedule 13D relates to 433,600 Shares beneficially owned by the Reporting Persons, which constitute approximately 5.42% of the issued and outstanding Shares. (b) The Manager has sole voting and dispositive power with respect to 433,600 Shares. Mr. Tepper has sole voting and dispositive power with respect to 433,600 Shares. (c) Within the past sixty days, the Reporting Persons purchased and sold Shares on the dates, in the amounts and at the prices set forth on Exhibit B annexed hereto and incorporated by reference herein. All of such purchases and sales were made on the open market. (d) Not applicable. (e)Not applicable. Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer There exist no contracts, arrangements, understandings or relationships (legal or otherwise) among the persons named in Item 2 and between such persons and any persons with respect to any securities of the Company, including but not limited to transfer or voting of any securities, finders' fees, joint ventures, loan or option agreements, put or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies. Item 7.Material to Be Filed as Exhibits Exhibit A:Joint Filing Agreement. Exhibit B: Transactions in Shares Within Past 60 Days. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: August 7, 1997 Appaloosa Management L.P. By:Appaloosa Partners Inc., Its General Partner By:/s/ David A. Tepper David A. Tepper President David A. Tepper /s/ David A. Tepper
SC 13D5th “Page” of 8TOC1stPreviousNextBottomJust 5th
EXHIBIT INDEX Exhibit Exhibit Name Page A Joint Filing Agreement 8 B Transactions in Shares Within Past 60 Days 9
SC 13D6th “Page” of 8TOC1stPreviousNextBottomJust 6th
EXHIBIT A JOINT FILING AGREEMENT In accordance with Rule 13d-1(f) under the Securities Exchange Act of 1934, as amended, the persons named below each hereby agrees that the Schedule 13D filed herewith and any amendments thereto relating to the acquisition of shares of beneficial interest of Imagyn Medical, Inc. is filed jointly on behalf of each such person. Dated: August 7, 1997 Appaloosa Management L.P. By:Appaloosa Partners Inc., Its General Partner By:/s/ David A. Tepper David A. Tepper President David A. Tepper /s/ David A. Tepper
SC 13D7th “Page” of 8TOC1stPreviousNextBottomJust 7th
EXHIBIT B Transactions in Shares of the Company Within the Past Sixty Days Appaloosa Investment Limited Partnership I Number of Shares Purchase / Trade Purchased / Price per Sale Date Sold Share P 07-02-97 7,341 5.5608 P 07-11-97 3,670 6.0000 P 07-14-97 2,447 6.0000 S 07-16-97 1,225 6.5750 P 07-18-97 490 6.8000 P 07-18-97 9,788 6.7500 P 07-21-97 108,160 6.7500 P 07-22-97 38,550 6.7729 P 07-22-97 8,130 6.7500 P 07-24-97 4,065 6.6250 P 07-24-97 28,055 6.6478 P 07-25-97 4,065 6.3750 P 07-28-97 4,065 6.2500 P 07-29-97 1,220 6.3000 P 07-30-97 2,025 6.2500 P 07-31-97 2,430 6.2375 P 08-01-97 810 6.2375 P 08-01-97 4,065 6.3100 P 08-04-97 8,100 6.1875 P 08-06-97 9,477 6.2500 P 08-06-97 56,700 6.6875 P 08-06-97 20,250 6.7275 P 08-07-97 12,150 6.7275 P 08-07-97 2,430 6.7500
SC 13DLast “Page” of 8TOC1stPreviousNextBottomJust 8th
Palomino Fund Ltd. Number of Shares Purchase / Trade Purchased / Price per Sale Date Sold Share P 07-02-97 5,973 5.5608 P 07-11-97 2,987 6.0000 P 07-14-97 1,991 6.0000 S 07-16-97 995 6.5750 P 07-18-97 398 6.8000 P 07-18-97 7,964 6.7500 Reliance Standard Life Insurance Company Number of Shares Purchase / Trade Purchased / Price per Sale Date Sold Share P 07-02-97 1,686 5.5608 P 07-11-97 1,405 6.0000 S 07-16-97 280 6.5750 P 07-18-97 112 6.8000 P 07-18-97 2,248 6.7500 P 07-21-97 24,840 6.7500 P 07-22-97 8,850 6.7729 P 07-22-97 1,870 6.7500 P 07-24-97 935 6.6250 P 07-24-97 6,445 6.6478 P 07-25-97 935 6.3750 P 07-28-97 935 6.2500 P 07-29-97 280 6.3000 P 07-30-97 475 6.2500 P 07-31-97 530 6.2375 P 08-01-97 140 6.2375 P 08-01-97 935 6.3100 P 08-04-97 1,900 6.1875 P 08-06-97 2,223 6.2500 P 08-06-97 13,300 6.6875 P 08-06-97 4,750 6.7275 P 08-07-97 2,850 6.7275 P 08-07-97 570 6.7500

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘SC 13D’ Filing    Date First  Last      Other Filings
Filed on:8/7/9746None on these Dates
8/6/971
 List all Filings 
Top
Filing Submission 0000923088-97-000013   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 6:24:38.1am ET